| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +7.9% | +3.1% |
| R&D Expense | $3.5M | +9.3% | -2.2% |
| SG&A Expense | $5.6M | -7.2% | -0.6% |
| Operating Income | -$11.4M | +6.4% | +5.5% |
| Income Tax | $8K | -27.3% | -38.5% |
| Net Income | -$11.5M | +3.0% | -1.6% |
| EPS (Basic) | -$0.26 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.9M | +3.3% | -14.1% |
| Accounts Receivable | $5.4M | -10.2% | +45.2% |
| Inventory | $21.1M | +2.5% | -0.9% |
| Current Assets | $70.0M | +16.3% | -20.5% |
| Total Assets | $84.4M | +11.7% | -20.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.8M | — | — |
| Capital Expenditures | $758K | — | — |
| Investing Cash Flow | $10.4M | — | — |
| Financing Cash Flow | $19.3M | — | — |
| Free Cash Flow | -$28.6M | — | — |
| +0.0% |
| EPS (Diluted) | -$0.26 | +3.7% | +0.0% |
| $16.5M |
| +0.9% |
| +3.9% |
| Long-term Debt | $18.8M | — | — |
| Total Liabilities | $40.1M | +90.5% | +86.7% |
| Stockholders' Equity | $44.3M | -18.7% | -47.5% |